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Abstract
The airway epithelium is exposed to a variety of harmful agents during breathing and appro-
priate cellular responses are essential to maintain tissue homeostasis. Recent evidence
has highlighted the contribution of epithelial barrier dysfunction in the development of many
chronic respiratory diseases. Despite intense research efforts, the responses of the airway
barrier to environmental agents are not fully understood, mainly due to lack of suitable in
vitromodels that recapitulate the complex in vivo situation accurately. Using an interdisci-
plinary approach, we describe a novel dynamic 3D in vitromodel of the airway epithelium,
incorporating fully differentiated primary human airway epithelial cells at the air-liquid inter-
face and a basolateral microfluidic supply of nutrients simulating the interstitial flow
observed in vivo. Through combination of the microfluidic culture system with an automated
fraction collector the kinetics of cellular responses by the airway epithelium to environmental
agents can be analysed at the early phases for the first time and with much higher sensitivity
compared to common static in vitromodels. Following exposure of primary differentiated
epithelial cells to pollen we show that CXCL8/IL–8 release is detectable within the first 2h
and peaks at 4–6h under microfluidic conditions, a response which was not observed in
conventional static culture conditions. Such a microfluidic culture model is likely to have util-
ity for high resolution temporal profiling of toxicological and pharmacological responses of
the airway epithelial barrier, as well as for studies of disease mechanisms.
Introduction
The barrier functions of the airway epithelium are centrally involved in regulating tissue
homeostasis in the lung and abnormal responses of the airway epithelium to the environment
are thought to contribute to the pathogenesis of chronic airway diseases like asthma and
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chronic obstructive pulmonary disease (COPD) [1]. However, despite intensive research, there
are still unmet medical needs in these diseases. One reason for this is the limited translation of
data from animal models into the human situation due to differences in lung morphology,
physiology and immunology [2]. Therefore, there is an urgent need for alternative human tis-
sue or cell-based in vitromodels in order to study the barrier functions of the airway epithe-
lium as close as possible to the in vivo situation [3].
Most commonly used in vitromodels of the airway epithelium consist of monolayers of
cells growing on the surface of standard cell culture wells or more complex models in which
cells are grown on a suspended porous support (e.g. Transwells
1
) to facilitate polarization and,
under certain conditions, differentiation [3]. Even when cells are able to differentiate and reca-
pitulate the in vivo structure, these systems are limited by their static nature. This is not repre-
sentative of the in vivo situation where there is constant circulation of fluids that supply and
remove an array of material (nutrients, metabolic waste products, hormones, mediators etc.)
within the local tissue environment. Thus, the interstitial fluid flow contributes to tissue main-
tenance and homeostasis. Apart from its role in mass transport, interstitial fluid flow also pro-
vides a specific physiological microenvironment (including sheer forces, viscosity and local
pressures) that is important for the normal functioning of interstitial cells such as fibroblasts
and endothelial cells [4, 5]. Recently, a new class of cell culture devices, so-called organs-on-a-
chip, have been developed incorporating continuous fluid flow for maintaining different cell
types or tissue constructs such as liver, skin, kidney, gut, lung, heart and brain [6]. With this
approach, long term cultures have been achieved and features that were not visible in static cul-
tures have been highlighted. ‘Lung-on-a-chip’ models have been used to analyse the effects of
flow rate [7], air liquid interface (ALI) culture under positive pressure [8], cyclic mechanical
stresses [9, 10] and air plugs [11] have on cellular viability, phenotype and response to chemical
stimuli/drugs. Organ-on-chip in vitromodels mostly use pulmonary cell lines, which do not
recapitulate the differentiated epithelium observed in vivo. The compatibility of these devices
with fully differentiated primary human lung epithelial cells has still to be demonstrated. Addi-
tionally, it is preferable for lung in vitromodels to include air-liquid interface culture in order
to be as close as possible to the in vivo situation. Several approaches have used the convenience
and robustness of commercially available permeable filter supports which allow cells to be
grown in advance using established cell culture techniques and to maintain quality control of
the cultures. For example, one organ-chip model has used a microfluidic circuit sustained by
an integrated micro-pump to create a multi-organ-chip comprised of different cell types grown
in filter supports to examine cross talk between two tissue types (e.g. skin and liver) [12, 13].
Other models have used a microfluidic channel to apply airflow to the apical side of differenti-
ated primary bronchial epithelial cells (PBECs) in order to analyse the effect of sheer stress on
ciliary function [14, 15]. However, none of the current devices have cell culture wells that are
individually supplied with nutrients to allow independent challenge and parallel measurement
of temporal responses under conditions that simulate interstitial flow.
Thus, the aim of this study was to develop a dynamic in vitro 3D model of the human airway
epithelium that can be challenged apically while the basolateral secretion of mediators can be
measured over time. Here we describe the design and fabrication of a multi-chamber culture
device that integrates standard permeable filter supports containing fully differentiated PBECs
with microfluidic flow to provide a constant basolateral supply of nutrients that simulates the
circulation of fluids in the tissue. The microfluidic culture system was compatible with stan-
dard permeable filter inserts and was interfaced with a fraction collector for automated collec-
tion of the eluate to facilitate analysis of the kinetic response to an environmental challenge of
differentiated PBECs at an air-liquid interface. The system was well tolerated by the
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differentiated cultures and, due to the small volume of the collected fractions, provided excel-
lent sensitivity for mediator detection.
Methods
Design and fabrication of the microfluidic culture system
The microfluidic culture system consists of 5 separate chambers that each houses a conven-
tional Transwell
1
, as shown in Fig 1. The design and fabrication is described in the online sup-
plement (S1 Methods).
Cell culture
Human PBECs were obtained by epithelial brushing using fiberoptic bronchoscopy from sub-
jects selected from a volunteer database without any chronic airway diseases. All procedures
were approved by the Southampton and South West Hampshire Research Ethics Committee
and were undertaken following written informed consent. Culture of PBECs is described in the
online supplement (S2 Methods). Filter supports with fully differentiated PBECs were inserted
into the microfluidic culture system and perfused with basal medium at a flow rate of 30μL/hr.
As a static culture control, filter supports with fully differentiated PBECs were cultured in stan-
dard cell culture wells containing 500 μL of basal medium. After a 1hr equilibration phase, dif-
ferentiated cells were apically stimulated with grass pollen extract (67μL) of an equivalent of
1mg Timothy grass (Phleum pratense) or BEBM as control for 24hrs as previously described
[16].
Analysis of epithelial barrier responses
In the microfluidic culture system the basolateral flow was collected at 2hr intervals with the
automated fraction collector. In static control experiments basolateral supernatant was col-
lected at matching time points. The concentration of CXCL8/IL–8 in supernatants was ana-
lysed by Human CXCL8/IL–8 DuoSet ELISA kit (R&D Systems, Abingdon, UK). The physical
barrier properties before and after stimulation were monitored by measuring TER.
Immunofluorescence staining
After fixation with 4% paraformaldehyde, cells were permeabilised with 0.1% Triton X–100,
blocked with 1% BSA in PBS and actin filaments were stained with Acti-Stain555-phalloidin
(Cytoskeleton, Denver, Colorado, US) and AlexaFluor
1
488-conjugated mouse anti-human
occludin antibody (clone OC-3F10, Life technologies) over night at 4°C. Subsequently, cells
were washed extensively and mounted on slides using ProLong Gold antifade reagent with
DAPI (Life technologies). Z-stacks were taken using LSM 6000 microscope (Leica Microsys-
tems, Wetzlar, Germany). After deconvolution using Leica Application Suite software z-projec-
tions were performed using ImageJ software.
Results
Flow rate optimization
A flow rate of 30μL/hr corresponds to a velocity of around 3μm/s in the widest part of the
microfluidic chamber underneath the Transwell
1
support (Fig 2). By collecting fractions from
the device each hr, we were able to assess the stability of the system. As shown in Fig 3a, the vol-
umetric flow rates stabilised after 4hrs to a volume of approximately 27μL/hr. The higher vol-
umes seen over the first 3hrs can be explained by a clearance of the apical liquid (added for
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Fig 1. Design and assembly of the microfluidic culture system. a: Schematic section of a culture well: cells are cultured on a Transwell
1
inserted in the
holder. A V-ring is used to seal the system. b: Schematic of the setup: each well is connected to the syringe pump. A plate is placed under the device and is
moved to allow for the time-resolved fraction collection. c: Exploded view of the assembly of a single well. Five layers of dry film photoresist are laminated on
top of a support layer. A holder is screwed on top of the support layer and a Transwell
1
is subsequently inserted together with the V-ring. The microfluidic inlet
is screwed in the holder while the outlet needle is glued on the bottom of the support layer.
doi:10.1371/journal.pone.0139872.g001
Fig 2. Simulation of the microfluidic flow in the chamber. a: Top view of the results of the simulation of half channel. Stream lines are represented in grey.
The colours and the scale bar are relative to the pressure along the channel [Pa]. b: 3D view of the simulated system. Stream lines are represented in grey. A
heat map of the values of the x component of the velocity in the widest section of the channel is reported together with the colour scale bar [μm/s]. c: Plot of
the gradient of the x component of the velocity along the y-axis versus the distance from the centre of the channel.
doi:10.1371/journal.pone.0139872.g002
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stimulation by the cells) by absorption across the epithelial cell layer, a process that can be reg-
ulated by active ion transport across the epithelium leading to iso-osmolar fluid clearance [17].
After 24hrs, the apical liquid volume in the microfluidic culture system was approximately half
of that in static culture conditions and closely resembled an air-liquid interface culture. Apical
stimulation of differentiated PBECs with pollen extract had no significant effect on the basolat-
eral volume, indicating an intact physical barrier without additional loss of fluid from the apical
compartment. The barrier integrity was evaluated by measuring the ionic permeability across
Fig 3. Characterization of microfluidic culture system.Differentiated PBECs were cultured in the
microfluidic culture system and after an equilibration phase of 1h apically exposed to pollen extract. a: The
flow rate of pollen-challenged and control wells was determined by measuring the outlet volume per hour for a
period of 12h. n = 7 independent experiments with different donors. b: The transepithelial electrical resistance
(TER) of differentiated PBECs was measured before and after microfluidic culture conditions without or with
pollen challenge. Cells cultured in common culture conditions without flow were used as static controls. TER
was normalized to the respective value before the start of the experiment. n = 15 independent experiments
using 13 different donors; *: p0.05.
doi:10.1371/journal.pone.0139872.g003
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the membrane by TER. After stimulation, the TER increased under either static or microfluidic
culture conditions (Fig 3b). This increase in TER is due to the application of liquid to the apical
surface [18, 19]. However, the fold increase in TER in microfluidic culture was significantly
lower than under static culture conditions. This is probably due to the reduction in the apical
fluid volume as a result of enhanced fluid clearance under microfluidic culture conditions.
Importantly, differentiated PBECs in microfluidic culture did not show an altered response to
pollen extract compared to static culture conditions as measured by TER. Since the TER is a
good indicator of the integrity of the physical barrier, differentiation status and viability of the
epithelium, it is highly unlikely that microfluidic culture conditions cause a change of these
properties. The integrity of the epithelial barrier during microfluidic culture conditions is fur-
ther shown by immunofluorescence staining with Acti-Stain555-phalloidin (Fig 4), which
showed that the actin filaments of the cytoskeleton were similar under microfluidic and static
culture conditions in their cellular localisation including stress-induced filaments. Further-
more, the transmembrane tight junction protein occludin, which is a regulator of tight junction
sealing and sensitive to barrier pertubations ([20–22]ref) was localised at cell-cell junctions and
no difference in the localisation was observed between microfluidic and static culture condi-
tions confirming the integrity of the physical barrier.
Release of the inflammatory mediator IL–8
After stimulation with pollen extract, differentiated PBECs released the inflammatory chemo-
kine CXCL8/IL–8 into the basolateral compartment (Fig 5). In static as well as microfluidic cul-
ture conditions, pollen induced a significant increase in IL–8 release (Fig 5a). The overall
amount of IL–8 released basolaterally over a 24hrs period was significantly increased in micro-
fluidic compared to static culture conditions. Additionally, the fold increase in IL–8 release
induced by pollen in microfluidic culture conditions was significantly higher than in static con-
ditions (Fig 5b). This increase in overall production of IL–8 in microfluidic culture conditions
might be explained by reduced feedback inhibition, since released IL–8 is constantly removed
via the microfluidic flow. In static culture conditions IL–8 accumulates constantly over time
and may inhibit production by a negative feedback loop. To test this hypothesis further experi-
ments investigating the transcriptional and translational control of CXCL8/IL–8 expression are
required.
Time-dependent release of IL–8
Microfluidic culture conditions coupled with the automated fraction collector provided the
capability to analyse time-dependent release of IL–8 over a period of 24hrs. After stimulation
with pollen extract, differentiated PBECs rapidly released significant amounts of IL–8 (Fig 6a),
reaching a maximum at 6hrs after stimulation. The release of IL–8 thereafter reduced up to
14hrs after stimulation, stabilizing at a constant value of around 5ng/mL. A slight shoulder
between 20–22hrs is seen, indicative of a second peak in IL–8 release; however, this increase
was not significant. Interestingly, such a time-dependent release of IL–8 could not be detected
in static culture conditions (Fig 6b), where aliquots of basolateral medium at matching time
points were analysed. Due to the higher culture medium volume, the concentration of IL–8
released in the basolateral medium of the static cultures was much lower than in the microflui-
dic culture system, which made it more difficult to measure the released mediator. Further-
more, due to the accumulation of IL–8 over time in the static culture, it was not possible to
detect the kinetic profile of the release of IL–8. In summary, the microfluidic culture conditions
enabled analysis of time-dependent mediator release by differentiated PBECs in response to
Bronchial Epithelial Cell Monitoring with Microfluidics
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environmental impacts with a much higher sensitivity than conventional static culture
conditions.
Discussion
We have developed a novel microfluidic culture system which allows experimental challenge of
up to 5 parallel cultures of differentiated PBECs contained in standard permeable filter sup-
ports combined with integration of an automated fraction collector to allow high resolution
temporal analysis of mediator release. This system allows use of conventional culture tech-
niques in which PBECs can be differentiated on permeable supports to produce a 3D construct
of the airway epithelium and, once fully differentiated, the cultures can be transferred to the
microfluidic culture system. In the dynamic culture model presented here, the microfluidic
flow guarantees a continuous supply of nutrients and removes metabolites to more accurately
reflect the circulation of fluids in vivo. It has been shown that the interstitial flow in the tissue
has a velocity between 0.1–2.0μm/s and can reach up to 4.0μm/s [23, 24]. In our microfluidic
culture system the velocity of the flow was maintained in this range to reflect the in vivo situa-
tion. Under these conditions, airway epithelial polarity was maintained in the microfluidic sys-
tem as determined by TER, indicating a differentiated and viable airway epithelium.
Combining the device with an automated fraction collector provided a means of analysing, in-
depth, the kinetics of mediator release induced by environmental challenge. Using the system,
we identified that apical exposure to grass pollen caused an early basolateral inflammatory
response, inducing release of IL–8 from differentiated PBECs within the first 6hrs. To our
knowledge, this is the first report showing the detailed kinetics of mediator release by differen-
tiated PBECs induced by an environmental agent.
A detailed understanding of the kinetics of airway epithelial mediator release in response to
environmental impacts should significantly enhance our knowledge of environment-to-epithe-
lial-to-tissue signalling pathways that are involved in airway homeostasis. Our data suggest
that microfluidic culture conditions offer the potential for high resolution temporal profiling of
Fig 4. Cell viability and barrier integrity of differentiated PBECs in microfluidic compared to static
culture conditions. After 24h in microfluidic or static culture conditions, actin filaments (yellow) and the tight
junction protein occludin (green) were stained by immunofluorescence. Images are representative of 3
independent experiments using 3 different donors.
doi:10.1371/journal.pone.0139872.g004
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epithelial barrier responses under conditions that more closely mimic the in vivo situation.
Analysing the kinetic release of inflammatory mediators by airway epithelial cells should pro-
vide insights into the temporal primacy of certain mediators over other cytokines that regulate
inflammation. Such data is crucial for targeting appropriate anti-inflammatory drugs. Further-
more, by enabling use of differentiated PBECs originating from individuals with chronic lung
Fig 5. Release of IL–8 in microfluidic compared to static culture conditions. Basolateral release of IL–8
by differentiated PBECs after challenge with pollen was analysed by ELISA. n = 6 independent experiments
using 5 different donors. a: Overall amount of IL–8 released by differentiated PBECs in a period of 24h after
pollen treatment. b: Comparison of pollen induced IL–8 release in static and microfluidic culture condition.
The x-fold change in pollen induced IL–8 release compared to untreated control is shown. Linked data points
represent experiments run in static and microfluidic culture conditions in parallel with matching PBEC donor.
*: p0.05 (Wilcoxon).
doi:10.1371/journal.pone.0139872.g005
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diseases, this dynamic 3D model of the airway mucosa has great potential to enhance our
understanding of underlying disease mechanisms, facilitate identification of new therapeutic
targets and optimize existing therapies.
Over the last 5 years, considerable effort has been invested into tissue engineering and
design of microfluidic culture platforms for epithelial cells from different origins including gut,
liver, skin, kidney and lung [25, 26]. Most microfluidic platforms for studying epithelial cell
behaviour incorporate a permeable membrane that divides the system into apical and basolat-
eral compartments. Epithelial cells are generally grown on the apical side of the permeable
Fig 6. Time-dependent release of IL–8 by differentiated PBECs induced by pollen. a: Using the
microfluidic culture system, basolateral flow was collected for 2h periods over 24h. Release of IL–8 was
analysed by ELISA. n = 15 independent experiments using 13 different donors. b: Comparison of pollen
induced IL–8 release in static and microfluidic culture conditions in 2h intervals over a 12h period. In static
culture conditions, aliquots of basolateral medium were taken at matching time points. Release of IL–8 was
analysed by ELISA. Microfluidic culture (MF) n = 15; static n = 5 independent experiments using 13 and 4
different donors respectively.
doi:10.1371/journal.pone.0139872.g006
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membrane. Many of these models are designed to address specific aspects of lung biology. For
example, a microfluidic platform was developed to analyse the dynamics and mechanical
stresses caused by liquid plugs in small airways using primary human cells [11, 27, 28]. Using
the alveolar epithelial cell line A549, Nalayanda et al. (2009) [29] developed an alternative
model with comparable larger basolateral channel volume. However, a specific biological ques-
tion was not addressed with this model. A revised and modified version was later developed in
order to analyse ventilator-induced injury of the respiratory epithelium using cell lines as a
model [30]. In this platform up to 4 cell culture wells were interconnected with media and air-
flow channels, however this did not allow for individual treatment and analysis. Another inter-
esting model of the alveolar epithelial barrier was developed by Ingber and colleagues [9]
incorporating cyclic mechanical strain of breathing. A co-culture model of the alveolar epithe-
lium using the cell line A549 and endothelial cells under cyclic strain was used to analyse the
barrier modulating effect of nanoparticles and neutrophil adhesion. However, the suitability of
this platform for primary human alveolar epithelial cells still needs to be confirmed. A similar
approach to our microfluidic culture system has been used by Wang et al. (2014) [14] for the
culture of human nasal epithelial cells. Here, the aim was to monitor cilia function with high
resolution microscopy. Due to the limited optical working distance of high magnification
lenses, they used an ‘upside-down’ approach with cells on the basolateral side of a permeable
filter support, directly facing a microfluidic channel. Airflow and medium were supplied from
the top of the insert without continuous flow. This model was used to analyse cilia beat fre-
quency in response to gaseous substances like formaldehyde. The combined use of primary
cells and microfluidics has recently highlighted the dependence of the transport behaviour of
kidney cells on external shear stresses and flow conditions [31]. However, none of the micro-
fluidic culture models described in the literature are suitable for high resolution analysis of the
mediator responses of differentiated PBECs to environmental stimuli.
Membrane based microfluidic platforms are also a useful tool for studying toxicology [32]
and the permeability of drugs across epithelial surfaces. Using the Caco–2 cell line as a model
of the intestine epithelium, Gao et al. (2013) [33] developed an integrated microfluidic device
with high resolution mass spectrometry in order to detect the passage of curcumin across the
epithelial barrier. A similar approach could be transferred into the microfluidic culture system
described here using primary human airway epithelial cells differentiated on commercially
available permeable filter supports at the air interface and used for analysing the passage of
respiratory drugs across the airway epithelium or even the passage of environmental airborne
substances and fumes.
The advantage of our microfluidic platform is that PBECs can be differentiated separately
using conventional well established culture techniques, which allows the user to regularly
check the cells over the 3 week differentiation period, e.g. for differentiation status or contami-
nating infections. This is particularly important when using PBECs from individuals with
chronic lung diseases as they are associated with defects in their epithelial barrier properties
and commonly bacterial infections, which increase the contamination risk to cultures. Since
the microfluidic culture system presented here is based around commercially available perme-
able filter supports, which are widely used and tested in established cell culture models, this
microfluidic platform can easily be translated into other epithelial models, like the skin, gut,
liver or kidney. Our microfluidic system combines 5 separate wells into one device for parallel
testing, and this could easily be scaled for higher throughput. It is user-friendly and suitable for
any cell-culture trained individual without a specialized microfluidic background. Further-
more, the model could also be used for drug safety and permeability studies with provision of
additional kinetic information. By using commercial available cell culture inserts and already
established cell culture techniques our microfluidic culture system can easily be expanded to
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more complex co-culture systems, e.g. combining airway epithelial cells with mesenchymal or
endothelial cells recapitulating the cellular composition of the airway tissue in vivo.
In summary, we have developed a microfluidic culture system for primary epithelial cells
which allows the kinetic analysis of barrier responses to environmental impacts and with a
much higher sensitivity than conventional static culture systems. The dynamic nature of the
system allows the continuous exchange of fluids and mediators which more closely mimics the
interstitial flow in vivo. This dynamic culture system will be a useful tool for analysing the
mechanisms of chronic lung diseases and help identifying new therapeutic strategies, as has
potential for toxicological or pharmacological studies as well.
Supporting Information
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(DOCX)
S2 Methods. Epithelial cell culture.
(DOCX)
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